Literature DB >> 10583388

Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein.

P Evenäs1, P García De Frutos, S Linse, B Dahlbäck.   

Abstract

Anticoagulant protein S interacts with the complement regulatory protein C4b-binding protein (C4BP) via its sex-hormone-binding globulin (SHB6)-like region, which contains two globular (G) domains. Similar G domains are found in Gas6, a protein homologous to protein S, which is not known to bind C4BP or to have any anticoagulant activity. To determine the relative importance of the two G domains in protein S for C4BP protein binding, three recombinant protein S chimeras were produced having either of the two globular domains, or the whole SHB6-like globulin region, replaced by corresponding parts from Gas6. The chimeras were tested for binding to immobilized C4BP using surface-plasmon-resonance technology and microtiter plate-based assays. In both systems, chimeras containing either only globular domains G1 or G2 from protein S were found to bind C4BP. Binding was stimulated by Ca2+ in a manner similar to that found for wild-type protein S. The affinities for C4BP of both chimeras containing individual G domains from protein S, were lower than that of wild-type protein S. Chimera II, containing the G1 domain from protein S, consistently bound C4BP more efficiently than chimera I, which had the protein S-derived G2 domain. The chimera containing the whole SHB6-like globulin region from Gas6 interacted considerably more weakly with C4BP. Our results demonstrate that both G domains of protein S are involved in the interaction between protein S and C4BP and that full affinity binding is dependent on contributions from both domains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583388     DOI: 10.1046/j.1432-1327.1999.00928.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Structure of the C-terminal laminin G-like domain pair of the laminin alpha2 chain harbouring binding sites for alpha-dystroglycan and heparin.

Authors:  D Tisi; J F Talts; R Timpl; E Hohenester
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

Review 2.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

3.  Dependence on vitamin K-dependent protein S for eukaryotic cell secretion of the beta-chain of C4b-binding protein.

Authors:  Sofia Carlsson; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

4.  The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling.

Authors:  Nour Al Kafri; Josefin Ahnström; Adrienn Teraz-Orosz; Ludovic Chaput; Natesh Singh; Bruno O Villoutreix; Sassan Hafizi
Journal:  Biochem Biophys Rep       Date:  2022-04-28

5.  Understanding the functional difference between growth arrest-specific protein 6 and protein S: an evolutionary approach.

Authors:  Romain A Studer; Fred R Opperdoes; Gerry A F Nicolaes; André B Mulder; René Mulder
Journal:  Open Biol       Date:  2014-10       Impact factor: 6.411

6.  Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.

Authors:  Adrienn Teraz-Orosz; Magdalena Gierula; Anastasis Petri; David Jones; Renos Keniyopoullos; Patricia Badia Folgado; Salvatore Santamaria; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood Adv       Date:  2022-01-25

7.  TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Authors:  Natalia Reglińska-Matveyev; Helena M Andersson; Suely M Rezende; Björn Dahlbäck; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

8.  High protein S activity due to C4b-binding protein deficiency in a 34-year-old Surinamese female with ischemic retinopathy.

Authors:  René Mulder; Jeroen K de Vries; Rogier P H M Müskens; André B Mulder; Michaël V Lukens
Journal:  Clin Case Rep       Date:  2018-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.